240 related articles for article (PubMed ID: 25527274)
41. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
42. SNX27-retromer assembly recycles MT1-MMP to invadopodia and promotes breast cancer metastasis.
Sharma P; Parveen S; Shah LV; Mukherjee M; Kalaidzidis Y; Kozielski AJ; Rosato R; Chang JC; Datta S
J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31820782
[TBL] [Abstract][Full Text] [Related]
43. CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.
Fan SH; Wang YY; Lu J; Zheng YL; Wu DM; Zhang ZF; Shan Q; Hu B; Li MQ; Cheng W
J Cell Biochem; 2015 Apr; 116(4):502-13. PubMed ID: 25213553
[TBL] [Abstract][Full Text] [Related]
44. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
45. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
46. [Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis].
Liu JL; Wei W; Tang W; Jiang Y; Yang HW; Li JT
Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1379-83. PubMed ID: 22883193
[TBL] [Abstract][Full Text] [Related]
47. ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis.
Dumortier M; Ladam F; Damour I; Vacher S; Bièche I; Marchand N; de Launoit Y; Tulasne D; Chotteau-Lelièvre A
Breast Cancer Res; 2018 Jul; 20(1):73. PubMed ID: 29996935
[TBL] [Abstract][Full Text] [Related]
48. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Eiseler T; Döppler H; Yan IK; Goodison S; Storz P
Breast Cancer Res; 2009; 11(1):R13. PubMed ID: 19243594
[TBL] [Abstract][Full Text] [Related]
49. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH
Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731
[TBL] [Abstract][Full Text] [Related]
50. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
51. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
52. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
53. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.
Zhang C; Chakravarty D; Sakabe I; Mewani RR; Boudreau HE; Kumar D; Ahmad I; Kasid UN
Mol Ther; 2006 May; 13(5):947-55. PubMed ID: 16455304
[TBL] [Abstract][Full Text] [Related]
54. Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.
Tang X; McMullen TPW; Brindley DN
Theranostics; 2019; 9(21):6129-6142. PubMed ID: 31534541
[TBL] [Abstract][Full Text] [Related]
55. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
56. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth.
Wyatt CA; Geoghegan JC; Brinckerhoff CE
Cancer Res; 2005 Dec; 65(23):11101-8. PubMed ID: 16322260
[TBL] [Abstract][Full Text] [Related]
57. New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
Delassus GS; Cho H; Eliceiri GL
J Cell Physiol; 2011 Dec; 226(12):3378-84. PubMed ID: 21344390
[TBL] [Abstract][Full Text] [Related]
58. The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor.
Seoane S; Perez-Fernandez R
Mol Endocrinol; 2006 Apr; 20(4):735-48. PubMed ID: 16322098
[TBL] [Abstract][Full Text] [Related]
59. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.
Mendes O; Kim HT; Stoica G
Clin Exp Metastasis; 2005; 22(3):237-46. PubMed ID: 16158251
[TBL] [Abstract][Full Text] [Related]
60. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
